Narrative review / 2006
Supplementation with conditionally essential nutrients showed favorable clinical effects across various cardiovascular diseases and risk factors.
This review evaluates controlled human studies on conditionally essential nutrients (CENs) in cardiovascular disease (CVD) therapy. The primary CENs reviewed based on human data are L-arginine, L-carnitine, propionyl-L-carnitine, and coenzyme Q10, with taurine and others noted to have more limited data. Collectively, CENs demonstrated favorable clinical effects in chronic heart failure, myocardial infarction, angina pectoris, and CVD risk factors including hypertension, hyperlipidemia, and lipoprotein(a). The authors note that additional controlled clinical studies of CENs in CVD are urgently needed.
- Study type
- Narrative review of controlled clinical studies
- Who was studied
- Patients with cardiovascular disease or CVD risk factors
- What was measured
- Clinical effects in chronic heart failure, MI, angina, and CVD risk factors
THE PAPER
Supplemental conditionally essential nutrients in cardiovascular disease therapy.
Kendler BS. J Cardiovasc Nurs, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.